+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Global Influenza Vaccines Market 2021 - 2027 - Product Thumbnail Image

Global Influenza Vaccines Market 2021 - 2027

  • Report
  • April 2021
  • 275 Pages
From
From
From
From
From
From
Global Virus Like Particles Market & Clinical Trial Insight 2023 - Product Thumbnail Image

Global Virus Like Particles Market & Clinical Trial Insight 2023

  • Clinical Trials
  • September 2017
  • 180 Pages
From
From
From
Vaccines 2020: World Market Analysis, Players, Trends - Product Thumbnail Image

Vaccines 2020: World Market Analysis, Players, Trends

  • Report
  • November 2020
  • 217 Pages
From
From
From
Disease Analysis: Seasonal Influenza Vaccines - Product Thumbnail Image

Disease Analysis: Seasonal Influenza Vaccines

  • Report
  • June 2021
  • 54 pages
From
Global Vaccines Market 2021-2025 - Product Thumbnail Image

Global Vaccines Market 2021-2025

  • Report
  • March 2021
  • 120 pages
From
From
Loading Indicator
adroll